Skip to main content
SpringerLink
Log in

Potential for immunotherapy: PEM as a target antigen

  • Chapter
Book cover Ovarian Cancer 3

Abstract

In looking for novel therapies for the effective treatment of ovarian cancer, particularly as an adjuvant to surgery, immunotherapy is an option which is ready to be explored. Two reasons why this option may now be a realistic one are that potential target antigens are being identified and considerable advances have been made in understanding the underlying mechanisms involved in tumour rejection and in antigen presentation and recognition by the various components of the immune system. The possibility of extending immunotherapy to prevention (at least for prevention of recurrence of the disease) is also a real one since active specific immunotherapy (ASI) appears to be unaccompanied by obvious serious side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hung, M.C., Zhang, X., Yen, D.H. et al. (1992) Aberrant expression of the c-erbB-2/ neu protooncogene in ovarian cancer. Cancer Lγett., 61, 95–103.

    Article  PubMed  CAS  Google Scholar 

  2. Campbell, I.G., Jones, T.A., Foulkes, W.D. et al. (1991) Folate-binding protein is a marker for ovarian cancer. Cancer Res., 51, 5329–38.

    PubMed  CAS  Google Scholar 

  3. Mazars, R., Pujol, P., Maudelonde, T. et al. (1991) p53 mutations in ovarian cancer: a late event? Oncogene, 6, 1685–90.

    PubMed  CAS  Google Scholar 

  4. Lamb, P. and Crawford, L. (1986) Characterization of the human p53 gene. Cancer Res., 6, 1379–85.

    CAS  Google Scholar 

  5. Van der Bruggen, P., Traversari, C., Chomez, P. et al. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.Science, 254,1643–7.

    Article  PubMed  Google Scholar 

  6. Hird, V., Snook, D., Dhokia, B. et al. (1993) Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. Br. J. Cancer, 68, 403–6.

    Article  PubMed  CAS  Google Scholar 

  7. Schwartz, R.H. (1992) Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71, 1065–8.

    Article  PubMed  CAS  Google Scholar 

  8. Linsley, P.S., Brady, W., Grosmaire, L. et al. (1992) Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation, J.Exp. Med., 173, 721–30.

    Google Scholar 

  9. Chen, L., Ashe, S., Brady, W.A. et al. (1992) Costimulation of antitumour immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71, 1093–102.

    Article  PubMed  CAS  Google Scholar 

  10. Browning, M.J. and Bodmer, W.F. (1992) MHC antigens and cancer: implications for T-cell surveillance. Curr. Opinion Immunol 4,613–18.

    Article  CAS  Google Scholar 

  11. Burchell, J. and Taylor-Papadimitriou, J. (1989) Antibodies to human milk fat globule molecules. Cancer Invest., 17, 53–61.

    Article  Google Scholar 

  12. Gendler, S.J., Lancaster, C.A., Taylor-Papadimitriou, J. et al. (1990) Molecular cloning and expression of the human tumourassociated polymorphic epithelial mucin. J. Biol Chem., 265, 15286–93.

    PubMed  CAS  Google Scholar 

  13. Ligtenberg, M., Vos, H., Gennissen, A. et al. (1990) Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J. Biol Chem., 265, 5573–8.

    PubMed  CAS  Google Scholar 

  14. Wreschner, D.H., Hareuveni, M., Tsarfaty, I. et al. (1990) Human epithelial tumor antigen cDNA sequences. Eur. J. Biochem., 189,463–73.

    Article  PubMed  CAS  Google Scholar 

  15. Siddiqui, J., Abe, M., Hayes, D. et al. (1988) Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma- associated antigen. Proc. Natl Acad. Sci. USA, 85,2320–3.

    Article  PubMed  CAS  Google Scholar 

  16. Lan, M., Batra, S., Qi, W-N. et al. (1990) Cloning and sequencing of a human pancreatic tumour mucin cDNA. J. Biol. Chem., 265, 15294–9.

    PubMed  CAS  Google Scholar 

  17. Burchell, J., Gendler, S.J., Taylor-Papadimitriou, J. et al. (1987) Development and characterisation of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer. Res., 47, 5476–82.

    PubMed  CAS  Google Scholar 

  18. Girling, J.R., Bartkova, J., Burchell, J. et al. (1989) A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int. J. Cancer, 43, 1072–6.

    Article  PubMed  CAS  Google Scholar 

  19. Gunn, J.R., Byrd, J., Hicks, J. et al. (1989) Molecular cloning of human intestinal mucin cDNAs. J. Biol Chem., 264, 6480–7.

    Google Scholar 

  20. Gum, J.R., Hicks, J., Swallow, D. et al. (1990) Molecular cloning of cDNAs derived from a novel human intestinal mucin gene.Biochem. Biophys. Res. Commun., 171,407–15.

    Article  PubMed  CAS  Google Scholar 

  21. Porchet, N., van Cong, N., Dufosse, J. et al. (1991) Molecular cloning and chromosomal localization of a novel human tracheobronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem. Biophys. Res. Commun., 175,414–22.

    Article  PubMed  CAS  Google Scholar 

  22. Langdon, S.P., Lawrie, S.S., Hay, F.G. et al. (1988) Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res., 48, 6166–72.

    PubMed  CAS  Google Scholar 

  23. Burchell, J., Taylor-Papadimitriou, J., Boshell, M. et al. (1989) A short sequence within the amino acid tandem repeat of a cancer associated mucin contains immunodominant epitopes. Int. J. Cancer, 44,691–6.

    Article  PubMed  CAS  Google Scholar 

  24. Taylor-Papadimitriou, J. (1991) Report on the First International Workshop on Carcinomaassociated Mucins. Int. J. Cancer, 49, 1–5.

    Article  PubMed  CAS  Google Scholar 

  25. Lancaster, C., Peat, N., Duhig, T. et al. (1990) Structure and expression of the human polymorphic epithelial mucin gene: an expressed VNTR unit. Biochem. Biophys. Res. Commun., 173, 1019–29.

    Article  PubMed  CAS  Google Scholar 

  26. Hanish, F.G., Uhlenbruck, G., Peter-Katalinic, J. et al. (1989) Structure of neutral O-linked polylactosaminoglycans on human skim milk mucins. A novel type of linearly extended poly-N-acetyl-lactosamine backbones with Galiβ(l-4) GlcNAciβ(l-6) repeating units. J. Biol Chem., 265, 872–83.

    Google Scholar 

  27. Hull, S.R., Bright, A., Carraway, K.L. et al. (1989) Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line.Cancer Commun., 1, 261–7.

    PubMed  CAS  Google Scholar 

  28. Van Daam, P.A., Lowe, D.G., Watson, J.V. et al. (1991) Multiparameter flow cytometric quantitation of the expression of the tumor- associated antigen SM3 in normal and neoplastic ovarian tissues. Cancer, 68,169–77.

    Article  Google Scholar 

  29. Granowska, M, Mather, S.J., Jobling, T. et al. (1990) Radiolabelled stripped mucin, SM3, monoclonal antibody for immunoscintigraphy of ovarian tumours. Int. J. Biol. Markers, 5, 89–96.

    PubMed  CAS  Google Scholar 

  30. Barnd, D.L., Lan, M.S., Metzgar, R.S. et al. (1989) Specific, major histocompatibilty complex-unrestricted recognition of tumor- associated mucins by human cytotoxic T cells.Proc. Natl. Acad. Sci. USA, 86, 7159–64.

    Article  PubMed  CAS  Google Scholar 

  31. Jerome, K.R., Barnd, K.L. Bendt, K.M. et al. (1991) Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognise an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.Cancer Res., 51, 2908–16.

    PubMed  CAS  Google Scholar 

  32. Rughetti, A., Turchi, V., Apolonj Ghetti, C. et al. (1993) Human B cell immune response against the polymorphic epithelial mucin (PEM). Cancer Res., 53, 2457–90.

    PubMed  CAS  Google Scholar 

  33. Fung, P.Y.S., Made], M., Koganty, R. et al. (1990) Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate. Cancer Res., 50, 4308.

    PubMed  CAS  Google Scholar 

  34. Singhal, A., Fohn, M. and Hakomori, S. (1991)Induction of α-N-acetylgalactosamine- O-serine/threonine (Tn) antigen-mediated. cellular immune response for active immunotherapy in mice. Cancer Res., 51, 1406–14.

    PubMed  CAS  Google Scholar 

  35. MacLean, G.D., Bowen-Yacyshyn, M.B., Samuel, J. et al. (1992) Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen- 43. Friedenreich) determinant using a synthetic carbohydrate antigen, J.Immunother., 11, 292–305.

    Article  PubMed  CAS  Google Scholar 

  36. Lalani, E.N., Berdichevsky, F., Boshell, M. et al. (1991) Expression of the gene coding for a human mucin in mouse mammary tumour cells can affect their tumorigenicity. J. Biol Chem., 266, 15420–6.

    PubMed  CAS  Google Scholar 

  37. Ding, L., Lalani, E.N., Reddish, M. et al. (1993) Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUCl mucin gene: effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUCl gene. J. Cancer Immunol Immunother., 36, 9–17.

    Article  CAS  Google Scholar 

  38. Vos, H.L., Devarayalu, Y., de Vries, Y. and Bornstein, P. (1992) Thrombospondin 3 (Thbs3), a new member of the thrombospondin gene family. J. Biol Chem., 267, 12192–6.

    PubMed  CAS  Google Scholar 

  39. Peat, N., Gendler, S.J., Lalani, E.N., (1992) Tissue-specific expression of a human polymorphic epithelial mucin (MUCl) in transgenic mice. Cancer Res., 52, 1954–60.

    PubMed  CAS  Google Scholar 

  40. Kovarik, A., Peat, N., Wilson, D. et al. (1993) Analysis of the tissue specific promoter of the MUCl gene. J.Biol Chem., 268,9917–26.

    PubMed  CAS  Google Scholar 

  41. Aldovini, A. and Young, R.A. (1991) Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature, 35, 1479–82.

    Google Scholar 

  42. Dranoff, G., Jaffee, E., Lazenby, A. et al. (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte- macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl Acad. Sci. USA, 90, 3539–43.

    Article  PubMed  CAS  Google Scholar 

  43. Tao, M.H. and Levy, R. (1993) A novel vaccine for B-cell lymphoma: idiotype/granulocyte- macrophage colony-stimulating factor fusion protein. Nature, 362, 755–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. Taylor-Papadimitriou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Peat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Burchell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Beverley
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynaecology, Northern General Hospital, Sheffield University, Sheffield, UK

    Frank Sharp  & Tony Blackett  & 

  2. The Samaritan Hospital for Women, St Mary’s Hospital Medical School, London, UK

    Peter Mason

  3. Division of Gynecologic Oncology, UCLA School of Medicine, Los Angeles, USA

    Jonathan Berek

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Chapman & Hall

About this chapter

Cite this chapter

Taylor-Papadimitriou, J., Peat, N., Burchell, J., Beverley, P., Smith, M. (1995). Potential for immunotherapy: PEM as a target antigen. In: Sharp, F., Mason, P., Blackett, T., Berek, J. (eds) Ovarian Cancer 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0136-4_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-0136-4_30

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-0138-8

  • Online ISBN: 978-1-4757-0136-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation